Whole genome analysis in patients with resected non-small cell lung cancer (WJOG16622L)

UMIN ID: UMIN000050729

Registered date:31/03/2023

Basic Information

• Recruitment status: Recruiting
• Health condition(s) or Problem(s) studied: Non-small cell lung cancer
• Date of first enrollment: 2023/06/15
• Target sample size: 200
• Countries of recruitment: Japan
• Study type: Observational

Outcome(s)

• Primary Outcome: Disease-free survival

Key inclusion & exclusion criteria

• Age minimum: 18years-old
• Age maximum: Not applicable
• Gender: Male and Female
• Exclude criteria: 1) Localized or systemically active infection requiring treatment. 2) Pregnant women, lactating women, women who may be currently pregnant, or cases of unwillingness to use contraception. 3) Clinically problematic psychiatric disorders precluding enrollment. 4) Requirement of continuous systemic administration of steroid, and the current use of an immunosuppressant. 5) History of severe hypersensitivity 6) History of interstitial lung disease, drug-induced interstitial lung disease, idiopathic pulmonary fibrosis, radiation pneumonitis requiring steroid therapy, or active interstitial lung disease. 7) Others judged by the investigator to be unsuitable for this study.

Related Information

• Primary Sponsor: West Japan Oncology Group
• Source(s) of Monetary Support: The Japan Agency for Medical Research and Development